Receptor reserve and turnover of alpha-2 adrenoceptors that mediate the clonidine-induced inhibition of rat locus coeruleus neurons in vivo

Journal of Pharmacology and Experimental Therapeutics

Volumn 281, Issue 2, 1997, Pages 690-698

  Pineda, Joseba ^a   Ruiz Ortega, J Angel ^a   Ugedo, Luisa ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

2 ETHOXY 1(2H) QUINOLINECARBOXYLIC ACID ETHYL ESTER; ALPHA 2 ADRENERGIC RECEPTOR; CLONIDINE;

ALPHA ADRENERGIC STIMULATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LOCUS CERULEUS; MALE; NERVE CELL EXCITABILITY; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR DENSITY; RECEPTOR OCCUPANCY;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; CLONIDINE; LOCUS COERULEUS; MALE; NEURONS; QUINOLINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-2;

EID: 0030954423     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. 2-adrenoceptor binding and function after irreversible inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ). Eur. J. Pharmacol. 116: 175-178, 1985.
2. ADLER, C. H., MELLER, E. AND GOLDSTEIN, M.: Receptor reserve at the alpha-2 adrenergic receptor in the rat cerebral cortex. J. Pharmacol. Exp. Ther. 240: 508-515, 1987.
3. 2-autoreceptors: Agonist dissociation constants and recovery after irreversible inactivation. Br. J. Pharmacol. 108: 370-375, 1993.
4. AKAOKA, H., SAUNIER, C. -F., CHERGUI, K., CHARLÉTY, P., BUDA, M. AND CHOUVET, G.: Combining in vivo volume-controlled pressure microejection with extracellular unit recording. J Neurosci. Methods 42: 119-128, 1992.
5. 2-adrenergic receptors exerting opposing effects on cAMP production. Receptor 2: 195-206, 1992.
6. 2-adrenoceptors in the rat brain. Mol. Pharmacol. 42: 846-855, 1992.
7. BELLEAU, B., MARTEL, R., LACASSE, G., MÉNARD, M., WEINBERG, N. L. AND PERRON, Y. G.: N-carboxylic acid esters of 1,2- and 1,4-dihydroquinolines. A new class of irreversible inactivators of the catecholamine receptors and potent central nervous system depressants. J. Am. Chem. Soc. 90: 823-824, 1968.
8. BLACK, J. W. AND LEFF, P.: Operational models of pharmacological agonism. Proc. R. Soc. Lond. 220: 141-162, 1983.
9. CEDARBAUM, J. M. AND AGHAJANIAN, G. K.: Noradrenergic neurones of the locus coeruleus: inhibition by epinephrine and activation by the alpha antagonist piperoxane. Brain. Res. 112: 413-419, 1976.
10. CEDARBAUM, J. M. AND AGHAJANIAN, G. K.: Catecholamine receptors on locus coeruleus neurons: Pharmacological characterization. Eur. J. Pharmacol. 44: 375-385, 1977.
11. 1A agonists. Synapse 14: 297-304, 1993.
12. COX, R. F. AND WASZCZAK, B. L.: Differences in dopamine receptor reserve for N-n-propylnorapomorphine enantiomers: single unit recording studies after partial inactivation of receptor by EEDQ. Mol. Pharmacol 34: 125-131, 1989.
13. 2-adrenoceptor density and function following irreversible antagonism with EEDQ. Br. J. Pharmacol. 112: 855-860, 1994.
14. 2-adrenoceptor agonists on locus coeruleus firing rate and brain noradrenaline turnover in N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ)-treated rats. Naunyn-Schmiedeberg Arch. Pharmacol. 343: 472-477, 1991.
15. FURCHGOTT, R. F. AND BURSZTYN, P.: Comparison of dissociation constants and of relative efficacies of selected agonists acting on parasympathetic receptors. Ann. N.Y. Acad. Sci. 144: 882-899, 1967.
16. FURCHGOTT, R. F.: The use of beta-haloalkylamines in the differentiation of receptors and in the determination of dissociation constants of receptor-agonist complexes. Adv. Drug Res. 3: 21-55, 1966.
17. GLEASON, M. M. AND HIEBLE, J. P.: Ability of SK&F 104078 and SK&F 104856 to identify alpha-2 adrenoceptor subtypes in NCB20 cells and guinea pig lung. J. Pharmacol. Exp. Ther. 259: 1124-1132, 1991.
18. GRENHOFF, J. AND SVENSSON, T. H.: Clonidine regularizes substantia nigra dopamine cell firing. Life Sci. 42: 2003-2009, 1988.
19. HAMILTON, C. A. AND REID, J. L.: The effects of phenoxybenzamine on specific binding and function of central α-adrenoceptors in the rabbit. Brain Res. 344: 89-95, 1985.
20. JAMES, M. K., MORGAN, P. H. AND LEIGHTON, H. J.: A new method for estimation of agonist dissociation constants (Ka): directly fitting the postinactivation concentration-response curve to a nested hyperbolic equation. J. Pharmacol. Exp. Ther. 249: 61-69, 1989.
21. KENAKIN, T. P.: Pharmacological Analysis of Drug-Receptor Interaction, 2nd ed. Raven Press, New York, 1993.
22. KENAKIN, T.: Drugs and receptors. An overview of the current state of knowledge. Drugs 40: 666-687, 1990.
23. LACROIX, D., BLIER, P., CURET, O. AND DE MONTIGNY, C.: Effects of long-term desipramine administration on noradrenergic neurotransmission: electrophysiological studies in the rat brain. J. Pharmacol. Exp. Ther. 257: 1081-1090, 1991.
24. LEATHERBARROW, R. J.: Using linear and non-linear regression to fit biochemical data. Trends Biochem. Sci. 15: 455-458, 1990.
25. LEFF, P., DOUGALL, I. G., HARPER, D. H. AND DAINTY, I. A.: Errors in agonist affinity estimation: do they and should they occur in isolated tissue experiments?. Trends Pharmacol. Sci. 11: 64-67, 1990.
26. 2-adrenoceptors in locus coeruleus neurons. Brain Res. 321: 180-182, 1984.
27. MACKAY, D.: Continuous variation of agonist affinity constants. Trends Pharmacol. Sci. 9: 156-157, 1988b.
28. MACKAY, D.: Concentration-response curves and receptor classification: null method or operational model?. Trends Pharmacol. Sci. 9: 202-205, 1988a.
29. MAHAN, L. C., MCKERNAN, M. AND INSEL, P. A.: Metabolism of alpha- and beta-adrenergic receptors in vitro and in vivo. Ann. Rev. Pharmacol. Toxicol. 27: 215-235, 1987.
30. MARWAHA, J. AND AGHAJANIAN, G. K.: Relative potencies of alpha-1 and alpha-2 antagonists in the locus ceruleus, dorsal raphe and dorsal lateral geniculate nuclei: an electrophysiological study. J. Pharmacol. Exp. Ther. 222: 287-293, 1982.
31. 1 adrenergic receptors in a nonfusing muscle cell line. J. Biol. Chem. 257: 875-879, 1982.
32. 2 dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: Selective protection by neuroleptics. J. Pharmacol. Exp. Ther. 233: 656-662, 1985.
33. MELLER, E., BOHMAKER, K., NAMBA, Y., FRIEDHOFF, A. J. AND GOLDSTEIN, M.: Relationship between receptor occupancy and response at striatal dopamine autoreceptors. Mol. Pharmacol. 31: 592-598, 1987.
34. 1A agonists. Mol. Pharmacol. 37: 231-237, 1990.
35. MELLER, E., GOLDSTEIN, M., FRIEDHOFF, A. J. AND SCHWEITZER, J. W.: N-ethoxycarbonyl-2-ethoxyl-1,2-dihydroquinoline (EEDQ): A new tool to probe CNS receptor function. Adv. Exp. Med. Biol. 235: 121-136, 1988.
36. 2-adrenoceptors mediating mydriasis in the rat. In Adrenoceptors: Structure, Mechanisms, Function. Advances in Pharmacological Science, ed. by E. Szabadi and C. M. Bradshaw, pp. 335-336, Birkhäuser Verlag, Basel, Switzerland, 1991.
37. 1-adrenoceptor density and functional response of rat vas deferens. Naunyn-Schmiedeberg Arch. Pharmacol. 327: 238-246, 1984.
38. MOTULSKY, H. J. AND RANSNAS, L. A.: Fitting curves to data using nonlinear regression: a practical and nonmathematical review. FASEB J. 1: 365-374, 1987.
39. MURASE, S., NISELL, M., GRENHOFF, J. AND SVENSSON, T. H.: Decreased sensory responsiveness of noradrenergic neurons in the rat locus coeruleus following phencyclidine or dizocilpine (MK-801): Role of NMDA antagonism. Psychopharmacology 109: 271-276, 1992.
40. NICHOLAS, A. P., HÖKFELT, T. AND PIERIBONE, V. A.: The distribution and significance of CNS adrenoceptors examined with in situ hybridization. Trends Pharmacol. Sci. 17: 245-255, 1996.
41. PARKER, R. B. AND WAUD, D. R.: Pharmacological estimation of drug-receptor dissociation constants. Statistical evaluation. I. Agonists. J. Pharmacol. Exp. Ther. 177: 1-12, 1971.
42. PAXINOS, G. AND WATSON, C.: The Rat Brain in Stereotaxic Coordinates, 2nd ed. Academic Press, Orlando, FL, 1986.
43. 2-adrenoceptor occupancy in vivo. Eur. J. Pharmacol. 212: 109-111, 1992.
44. PILC, A., VETULANI, J., NOMURA, S. AND ENNA, S. J.: An in vivo procedure for the selective inactivation of rat brain cerebral cortical α-adrenoceptors using N-Ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ). Brain Res. 493: 8-13, 1989.
45. PINEDA, J., UGEDO, L. AND GARCÍA-SEVILLA, J. A.: Stimulatory effects of clonidine, cirazoline and rilmenidine on locus coeruleus noradrenergic neurones: Possible involvement of imidazoline-preferring receptors. Naunyn-Schmiedeberg Arch. Pharmacol. 348: 134-140, 1993.
46. RUIZ-ORTEGA, J. A. AND UGEDO, L.: Pharmacological characterization of the alpha-2 adrenoceptor subtype that modulates the activity of locus coeruleus noradrenergic neurons in rat. 16th Annual Meeting of the European Neuroscience Association. Supp. 6 to Eur. J. Neurosci., 1993.
47. 2-adrenergic receptor subtype gene expression in rat brain. Mol. Brain Res. 21: 133-149, 1994.
48. STARKE, K: Presynaptic alpha-autoreceptors. Rev. Physiol. Biochem. Pharmacol. 107: 74-146, 1987.
49. STEPHENSON, R. P.; A modification of receptor theory. Br. J. Pharmacol. 11: 379-393, 1956.
50. SVENSSON, T. H., BUNNEY, B. S. AND AGHAJANIAN, G. K.: Inhibition of both noradrenergic and serotonergic neurones in the brain by the α-adrenergic agonist clonidine. Brain Res. 92: 291-306, 1975.
51. TIMMERMANS, P. B. M. W. M., DE JONGE, A., THOOLEN, M. J. M. C., WILFFERT, B., BATINK, H. AND VAN ZWIETEN, P. A.: Quantification relationships between α-adrenergic activity and binding affinity of α-adrenoceptor agonists and antagonists. J. Med. Chem. 27: 495-503, 1984.
52. 3H-RX821002 ligand binding. Pharmacol. Toxicol. 69: 341-350, 1991.
53. WAUD, D. R.: On the measurement of the affinity of partial agonists for receptors. J. Pharmacol. Exp. Ther. 170: 117-122, 1969.
54. 2 adrenoceptors which increase potassium conductance in rat locus coeruleus. Neuroscience 14: 95-101, 1985.